SEC Filing Summary: Charles River Laboratories International, Inc.
Business Context and Reporting Period
This Form 8-K, filed on November 5, 2025, reports the issuance of a press release detailing financial results for the third quarter ended September 27, 2025. The registrant, Charles River Laboratories International, Inc., is a Delaware corporation with principal executive offices in Wilmington, Massachusetts.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1), which is referenced but not reproduced in the body of this 8-K document.
Material Changes
The filing does not disclose specific material changes versus the prior comparable period. It serves solely as a notification that third-quarter results have been released to the public.
Guidance, Outlook, and Risks
The referenced press release includes "safe harbor" language under the Private Securities Litigation Reform Act of 1995, indicating the presence of forward-looking statements. The filing notes that risks relating to the company are set forth in other documents filed with the SEC. No specific guidance, outlook, or unusual items are detailed in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 5, 2025) for actual Q3 2025 financial figures.
- Verify forward-looking statements and associated risk factors in the press release.
- Check subsequent SEC filings for detailed risk disclosures referenced in the 8-K.
- Confirm the fiscal quarter end date of September 27, 2025, for accurate period comparison.